微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 57.78% | 3.06% | 13.07% | 61/157 | 50.55% | 泽璟制药 | 94.64% | 行业排名> |
| 2025-12-31 | 51.1% | -8.38% | -1.9% | 70/157 | 50.61% | 海创药业 | 99.82% | 行业排名> |
| 2025-09-30 | 52.09% | -9.37% | -4.17% | 69/157 | -2.2% | 海创药业 | 98.62% | 行业排名> |
| 2025-06-30 | 54.35% | -10.06% | -3.05% | 66/157 | 14.83% | 海创药业 | 99.57% | 行业排名> |
| 2025-03-31 | 56.06% | -10.74% | 0.52% | 61/157 | 31.96% | 海创药业 | 99.52% | 行业排名> |
| 2024-12-31 | 55.77% | -10.15% | -2.96% | 66/157 | 51.88% | 艾力斯 | 96.74% | 行业排名> |
| 2024-09-30 | 57.47% | -8.42% | -4.9% | 61/157 | 22.51% | 首药控股 | 98.96% | 行业排名> |
| 2024-06-30 | 60.43% | -1.8% | -3.79% | 51/157 | 33.12% | 迪哲医药 | 97.73% | 行业排名> |
| 2024-03-31 | 62.81% | 2% | 1.19% | 44/157 | 51.76% | 百利天恒 | 97.99% | 行业排名> |
| 2023-12-31 | 62.07% | 2.56% | -1.08% | 47/157 | 51.61% | 百利天恒 | 98.92% | 行业排名> |
| 2023-09-30 | 62.75% | 2% | 1.97% | 46/157 | 32.47% | 迈威生物 | 98.93% | 行业排名> |
| 2023-06-30 | 61.54% | -9.4% | 1.68% | 54/157 | 38.42% | 迈威生物 | 99.59% | 行业排名> |
| 2022-12-31 | 60.52% | -7.89% | -7.89% | 56/157 | 53.83% | 迈威生物 | 99.8% | 行业排名> |
| 2021-12-31 | 65.71% | 2% | -3.26% | 51/157 | 55.2% | 迈威生物 | 99.46% | 行业排名> |
| 2021-06-30 | 67.93% | 2% | 2% | 42/157 | 47.23% | 迈威生物 | 99.75% | 行业排名> |